<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Protocol dobutamine stress Tc99m SPECT*&lt;SUP&gt;¶&lt;/SUP&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Protocol dobutamine stress Tc99m SPECT*<sup>¶</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Protocol dobutamine stress Tc99m SPECT*<sup>¶</sup></div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Standard dobutamine infusion protocol for pharmacologic stress testing with myocardial perfusion imaging. The dobutamine dose is increased every three minutes until the patient achieves at least 85% of maximum predicted heart rate (MPHR). If the heart rate remains &lt;85% MPHR following infusion of dobutamine 40 mcg/kg/min, arm exercise can be performed and/or atropine may be infused in an effort to further increase the heart rate. The radiopharmaceutical may be injected at any point once the patient's heart rate exceeds 85% MPHR or the development of symptoms.</div><div class="graphic_footnotes">SPECT: single photon emission computed tomography.<br/>* Addition of atropine, arm exercise at 15 minutes if heart rate remains &lt;85% maximum predicted.<br/>¶ Imaging should occur 15 to 45 minutes after protocol.<br/>Δ​ Injection of the radiopharmaceutical should take place once the patient's heart rate has reached ≥85% of the MPHR. This may occur at any dose of the dobutamine infusion.</div><div id="graphicVersion">Graphic 58697 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
